SAB2100037

Sigma-Aldrich

抗ACTB ウサギ宿主抗体

affinity isolated antibody

別名:
抗PS1TP5BP1抗体, 抗β-アクチン抗体
MDL番号:

由来生物

rabbit

抗体製品の状態

affinity isolated antibody

antibody product type

primary antibodies

クローン

polyclonal

形態

lyophilized powder

分子量

42 kDa

species reactivity

rat, zebrafish, goat, human, mouse, bovine, horse, pig, sheep, Caenorhabditis elegans

濃度

0.5 mg - 1 mg/mL

アプリケーション

western blot: suitable

結合体

unconjugated

UniProtアクセッション番号

保管温度

−20°C

Gene Information

human ... ACTB(60)

免疫原

The immunogen for anti-ACTB antibody: synthetic peptide derected towards the middle region of human ACTB

シーケンス

Synthetic peptide located within the following region: TMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRK

物理的形状

Lyophilized from PBS buffer with 2% sucrose

免責事項

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

RIDADR

NONH for all modes of transport

ドイツ水質汚染分類

WGK 3

引火点(°F)

Not applicable

引火点(℃)

Not applicable

試験成績書(COA)
原産地証明書(COO)
Yingshan Liu et al.
Experimental and therapeutic medicine, 9(4), 1401-1406 (2015-03-18)
The ability of metformin, an antidiabetic drug with wide applications, to inhibit tumor cell growth has recently been discovered. The PI3K/Akt signaling pathway has been found to play an important role in the survival, proliferation and apoptosis of tumor cells....
Xinjian Zhu et al.
Frontiers in cellular neuroscience, 11, 377-377 (2017-12-14)
Epilepsy is one of the most common chronic neurological disorders which provoke progressive neuronal degeneration. Endoplasmic reticulum (ER) stress has recently been recognized as pivotal etiological factors contributing to epilepsy-induced neuronal damage. However, the specific contribution of epilepsy made to...
Dongmei Han et al.
Molecular medicine reports, 11(4), 2896-2902 (2014-12-09)
A pharmaceutical composition (patent no. WO2012079419) exhibited favorable outcomes in a clinical trial of wet age‑related macular degeneration. The aims of the present study were to explore the effects of one composition component, charred Radix et Rhizoma Rhei (CRRR), in...
Yongjun Zhang et al.
Experimental and therapeutic medicine, 16(4), 2931-2937 (2018-09-15)
Gastric cancer is the third leading cause of cancer-associated deaths worldwide. Research into the underlying mechanisms of gastric cancer is essential for the development of novel therapeutic agents to improve the prognoses of patients with gastric cancer. Tanshinone IIA (Tan...
Nengxing Lin et al.
Oncology letters, 13(3), 1078-1082 (2017-04-30)
Cutaneous squamous cell carcinoma (cSCC) is a malignancy of epidermal keratinocytes that is responsible for ~20% of annual skin cancer-associated mortalities. Accumulating evidence demonstrates that the dysregulation of micro (mi)RNAs serves a significant role in the tumorigenesis and progression of...

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

テクニカルサービス連絡先

ソーシャルメディア

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

研究、開発、製造

私たちは、バイオテクノロジーと医薬品の研究&開発および製造のソリューションとサービスを提供する、グローバルなライフサイエンス業界のリーディングサプライヤーです。

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

当ウェブサイトのいかなる内容についても、許可なく複写することを禁じます。